KU Cancer Center breaks ground for new complex

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Do multi-cancer detection tests provide a net benefit? NCI aims to answer this question, beginning with the Vanguard feasibility trial which recently started accruing patients.

July 30, 2025

Vol.51 No.29

Clinical Conversation with The Cancer Letter

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

The first large cancer screening/early detection initiative to be launched in 2025—the NCI-funded Vanguard study of multi-cancer detection tests—has started accruing patients through nine sites across the U.S.

July 25, 2025

Vol.51 No.29

By Sara Willa Ernst, Jacquelyn Cobb and Paul Goldberg

Cancer Policy

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

NCI announced that the paylines for R01 grants for established and new investigators are expected to drop to the 4th percentile—a historic low for the institute.

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

NCI has initiated a pilot study to address the feasibility of using multi-cancer detection, or MCD, tests in future randomized controlled trials.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Mayo Clinic researchers link CAR T-cell aging to cancer relapse

The aging process known as senescence is a mechanism involved in the failure of CAR T-cell therapy, according to a study by researchers at the Mayo Clinic.

July 18, 2025

Vol.51 No.28

Cancer Policy

Supreme Court lifts lower-court freeze on RIFs

The U.S. Supreme Court has temporarily lifted a lower court’s freeze on the Trump administration’s reductions in force, or RIFs, freeing the government to continue their large-scale restructuring of the federal government.

July 11, 2025

Vol.51 No.27

By Jacquelyn Cobb

KU Cancer Center breaks ground for new complex

YOU MAY BE INTERESTED IN

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

Mayo Clinic researchers link CAR T-cell aging to cancer relapse

Supreme Court lifts lower-court freeze on RIFs

Renew today!

Subscriber content

Never miss an issue!

Login